AI in elite sport — key legal considerations around ‘performance enhancing technology’

AI is enhancing performance and even scouting future talent in elite sport. Sports technology and data are key to success, but come with legal risks.
We make the difference. Talk to us: 0333 004 4488 | hello@brabners.com
AuthorsPaddy FearnonColin Bell

As artificial intelligence (AI) advances at pace, it raises complex questions for intellectual property (IP) law. Could these innovations redefine what’s patentable? The Court of Appeal’s decision in Emotional Perception AI Limited (Appellant) v Comptroller General of Patents (Respondent) provides important clarity.
Here, Paddy Fearnon and Colin Bell explore the key issues from the case and consider the practical implications for those operating in the technology, creative and data-driven sectors.
Emotional Perception AI Ltd (EPAI) sought to patent a system that recommends media files like music tracks to users. The system’s novelty lay in its use of an artificial neural network (ANN) to recommend content based on human perception, rather than relying on traditional categories like genre.
The dispute centred on section 1(2) of the Patents Act 1977 which excludes “a program for a computer… as such” and mathematical methods from patentability. The question — do ANNs fall within this exclusion?
An ANN is a type of machine learning model inspired by the way that the human brain processes information. It consists of layers of interconnected ‘neurons’ that process data by applying weights and biases to inputs and producing outputs. ANNs learn patterns through a training process, adjusting these weights to improve performance. Once trained, they can perform tasks such as recognising images, interpreting language or — as in this case — recommending media files based on perceived similarity.
The court held that both hardware and software ANNs are caught by the exclusion in section 1(2) of the Patents Act 1977. This is because the trained weights and biases function as instructions that tell the machine how to process information. Whether those instructions are written by a human or learned by a machine does not matter. Therefore, the ANN could not be patented.
A central issue was whether the invention made a ‘technical contribution’ beyond the excluded subject matter. The invention’s core purpose — recommending files based on meaning-based similarity — was deemed subjective and aesthetic, not technical. The use of technical tools like ANNs do not automatically make the contribution technical.
The judgment clarified that — for the purposes of the exclusion — there’s no meaningful distinction between hardware and software ANNs. Both are treated as computers running a program and both are subject to the same legal analysis.
The court noted that — even if the ANN was not considered a ‘program for a computer’ — it could still fall under the mathematical method exclusion in section 1(2)(a) of the Patents Act 1977. Pure mathematical methods are not patentable unless they produce a technical effect like controlling a machine or improving system performance. In this case, the effect was limited to making recommendations based on emotional similarity which the court held was not technical.
This ruling sends a clear message that AI inventions that hinge on subjective outcomes like emotional similarity will face an uphill battle for patent protection. It’s not enough to use innovative technology — the contribution must be technical in nature for patentability in the UK.
For innovators developing AI solutions, this means that:
EPAI was granted permission to appeal the decision to the Supreme Court with the hearing held on 21 and 22 July 2025.
The issues in question were:
“Does the statutory restriction on patenting a program for a “program for a computer…as such” apply to artificial neural networks (“ANNs”)? If so, does it prevent the Appellant’s application from being patented?”
Put simply, EPAI argues that its ANN has a technical contribution and technical effect and therefore should not be considered excluded matter. The company is asking the court to adopt an approach more similar to the European Patent Office (EPO) rather than the stricter stance taken by the UK Intellectual Property Office (UKIPO).
The decision is expected in the coming weeks, likely by the end of 2025 or early 2026, though historically decisions can take longer than expected.
Our specialist IP lawyers will be monitoring the Supreme Court’s decision closely and will provide further updates in due course. With extensive experience in patent applications, disputes and all other areas of IP, we’re well placed to advise on how this ruling may affect your innovation strategy.
Talk to us by giving us a call on 0333 004 4488, sending us an email at hello@brabners.com or completing our contact form below.


Loading form...

AI is enhancing performance and even scouting future talent in elite sport. Sports technology and data are key to success, but come with legal risks.

We discuss the key opportunities and considerations shaping the future of sustainable AI and quantum‑powered technology.

We break down what the ICO found and outline three key steps that UK businesses should take now.

We explore how the UK’s shift to clean power is reshaping industry, infrastructure and the future of energy security.

We break down the key proposed reforms in the Digital Omnibus Package and outline what businesses should do to prepare.

We explain where generative AI has the potential to damage individuals’ reputations and examine relevant case law from other jurisdictions.

We discuss the mounting dangers of AI-powered cybercrime across the world of sport with David Andrew — the Founder and Managing Partner of Tiaki.

We explain the importance of the Supreme Court decision and what it means for innovators looking to gain patent protection for computer-related inventions.

We outline the key takeaways from our Games Tech Connect session on how generative AI is being used in video game development.

We outline what you need to know about the UKIPO's proposed fee increases across patents, trade marks and designs.

We explain the impact of the cyber-attack on JLR's workforce and outline what to do to protect your business and minimise the impact if an incident occurs.

We outline eight key steps to put your organisation in the strongest position for a prompt and effective response to any cyber-attack.

Some tech businesses are exploring how their commercial frameworks could evolve through smarter, values-driven contracting.

We explore recent examples of how brands are responding to dupe culture and outline practical steps that retail businesses can take to protect their brand.

We explore the potential of AI Growth Zones to transform the region through investment and job creation while also highlighting ongoing environmental concerns.

We break down the key takeaways from the final ruling and consider what they mean for the evolving relationship between IP law and AI development.

We explore how charities will need to manage their marketing activities and supporter consent once the secondary legislation takes effect.

We explore how AI is influencing football on and off the pitch, highlighting the real-world examples of its impact and the risks that come with it.

We explore the confusion surrounding OpenAI’s recent policy update on legal, medical and financial advice.

We explore how weak cybersecurity and slow responses can trigger major data breaches and resulting ICO fines.

At the Future of Retail: Risk & Resilience Conference 2025, leading voices explored the challenges and opportunities shaping the sector.

We explore the potential impact of AI on existing copyright laws and delve into the other IP and cross-border issues that arise from the use of global AI tools.

We explore the UK's evolving stance on AI regulation, spotlighting a proposed bill for a central AI authority.

We explore the main issues that influencers and brands need to consider before entering into partnerships.

The Medicines and Healthcare Products Regulatory Agency (MHRA) is continuing to roll out a suite of reforms designed to modernise oversight, enhance patient safety and support innovation.